Discovery of Potential Inhibitors of SARS-CoV-2 Main Protease by a Transfer Learning Method

The COVID-19 pandemic caused by SARS-CoV-2 remains a global public health threat and has prompted the development of antiviral therapies. Artificial intelligence may be one of the strategies to facilitate drug development for emerging and re-emerging diseases. The main protease (M(pro)) of SARS-CoV-...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Huijun, Liang, Boqiang, Sang, Xiaohong, An, Jing, Huang, Ziwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10143255/
https://www.ncbi.nlm.nih.gov/pubmed/37112871
http://dx.doi.org/10.3390/v15040891

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10143255/
https://www.ncbi.nlm.nih.gov/pubmed/37112871
http://dx.doi.org/10.3390/v15040891

Ejemplares similares